Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

M. D. Anderson study finds strong relationship between high body mass index, pancreatic cancer

25.06.2009
Early age of excess weight associated with younger age of diagnosis; obesity before diagnosis linked to poor outcome

In reviewing the weight history of pancreatic cancer patients across their life spans, researchers at The University of Texas M. D. Anderson Cancer Center have determined that a high body mass index in early adulthood may play a significant role in an individual developing the disease at an earlier age.

The study, published in the June 24 issue of the Journal of the American Medical Association, also found that patients who are obese the year before diagnosis have a poorer outcome than those who are not.

While excess weight is a known risk factor associated with pancreatic cancer, before now, few studies have looked at patients' body mass index (BMI) throughout their lifetime rather than simply at adulthood and/or year of disease diagnosis.

"This is the first study to explore at which ages excess body weight predisposes an individual to pancreatic cancer," said Donghui Li, Ph.D., professor in M. D. Anderson's Department of Gastrointestinal Medical Oncology and the study's corresponding author. "With our epidemiological research, we aimed to demonstrate the relationship between BMI and risk of pancreatic cancer across a patient's life span and determine if there was a time period that specifically predisposes an individual to the disease, as well as the link between BMI and cancer occurrence and overall survival of the disease."

Pancreatic cancer is the fourth leading cause of cancer death in men and women in this country. It is a highly lethal disease - according to the American Cancer Society, more than 42,470 persons will be diagnosed and 35,240 will likely die from the disease in 2009. The median survival for patients with the disease is less than 10 months and the five-year survival rate is less than five percent.

Obesity and smoking are the major modifiable risk factors associated with the disease; it's estimated that 25 percent of the pancreatic cancer cases are associated with the former and 27 percent with the latter, said Li. While the number of adults smoking is on the decline, the number of adults dangerously overweight is on the rise. In the U.S., obesity in adults has increased by 60 percent in the last 20 years, and is considered an epidemic by the Centers for Disease Control.

"With our study, we hoped to better understand the cause-and-effect relationship between this modifiable risk factor that contributes to the development of pancreatic cancer, in hopes that high-risk individuals can be identified and preventive measures discovered for this lethal disease," said Li.

For the case-control study, the researchers enrolled 1,595 individuals - 841 pancreatic adenocarcinoma patients treated at M. D. Anderson for their disease between 2004 and 2008, compared to 754 cancer-free individuals, all companions of M. D. Anderson patients. The groups were matched by age, race and sex. Using a detailed questionnaire, personal interviews were conducted to collect such information as their: smoking history; family history of cancer; alcohol use and general medical history. Participants also were asked to recall their height and body weights at ages 14-19; 20s; 30s; 40s; 50s; 60s; 70s; and the year prior to pancreatic cancer diagnosis or enrollment in the study.

Participants' BMI were then calculated at each age period and then classified by World Health Organization guidelines as either normal, overweight (greater than or equal to a score of 25, but less than 30) or obese (30 or greater). The researchers then compared the prevalence of overweight and obesity between both the patients and the controls. Among the cancer patients, they also compared the mean or median age of pancreatic cancer diagnosis and the overall survival time between those that were of normal weight, overweight and obese,.

While the research reconfirmed an association with obesity and pancreatic cancer, the study also found an association that excess at younger ages had a stronger association with increased risk of pancreatic cancer than subsequent increases in BMI. For example, individuals overweight at 14-19 and/or in their 30s had a 60 percent increased risk of the disease. Those obese at age 20s-40s were found to have a 2-3 times higher risk of pancreatic cancer. The risk of developing the disease appeared to level off for those that gained excess weight in their 40s; and after age of 50, the risk for the disease was not statistically significant.

Another major finding was the association between excess weight and earlier onset of pancreatic cancer. The study found a median age at diagnosis of 64 for those at normal weight, compared to 61 and 59 for overweight and obese patients respectively.

"This is one of the most surprising findings," said Li "On average, overweight pancreatic cancer patients were diagnosed two to three years earlier, and obese patients were diagnosed five to six years earlier, which underscores the impact of obesity on loss of life - especially in productive years."

The researchers also found that obesity later in life, especially within a year prior to a patient's cancer diagnosis, was associated with a reduced overall survival time. For example, said Li, in the study population, patients with a healthy body weight had an average survival time of 18 months, compared to 13 months for both overweight and obese patients.

"As we see obesity dangerously on the rise in the country, this study has true public health implications. Like smoking, obesity is a modifiable risk factor," said James Abbruzzese, M.D., professor and chair of the Department of Gastrointestinal Medical Oncology and the last author on the study. "Our study suggests that weight control at a younger age should be the primary preventive strategy to reduce the risk of pancreatic cancer."

The study may even have clinical implications, especially in regard to poor survival and obesity the year before diagnosis, as this association could affect pancreatic cancer clinical trial stratification in the future, explained Abbruzzese.

As future research, the researchers plan to further investigate the link between obesity, pancreatic cancer and poor outcome, looking at insulin resistance as a possible mechanism. Li and her team will also research what factors - genetic, dietary or others - modify the risk between excess body weight and the disease, in hopes of one day developing preventive strategies and discovering biomarkers for early detection of the disease.

In addition to Li and Abbruzzese, M. D. Anderson authors on the study include: Manal Hassan, M.D., Ph.D., assistant professor in the Department of Gastrointestinal Medical Oncology; Melissa Bondy, Ph.D.; professor in the Department of Epidemiology; and Jeffrey S. Morris, Ph.D., associate professor, and Jun Liu, M.S., statistical analyst, both in the Department of Biostatistics. R. Sue Day, Ph.D., of The University of Texas School of Public Health at Houston also contributed to the study.

About M. D. Anderson

The University of Texas M. D. Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. M. D. Anderson is one of only 40 comprehensive cancer centers designated by the National Cancer Institute. For four of the past six years, including 2008, M. D. Anderson has ranked No. 1 in cancer care in "America's Best Hospitals," a survey published annually in U.S. News & World Report.

Scott Merville | EurekAlert!
Further information:
http://www.mdanderson.org

More articles from Studies and Analyses:

nachricht Europe’s Demographic Future. Where the Regions Are Heading after a Decade of Crises
10.08.2017 | Berlin-Institut für Bevölkerung und Entwicklung

nachricht Scientists reveal source of human heartbeat in 3-D
07.08.2017 | University of Manchester

All articles from Studies and Analyses >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

New insights into the world of trypanosomes

23.08.2017 | Life Sciences

New Test for Rare Immunodeficiency

23.08.2017 | Life Sciences

Cholesterol-lowering drugs may fight infectious disease

22.08.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>